<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>School of Mathematics &amp; Statistics</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1F3E892-4604-464E-800E-922FD6C84A18"><gtr:id>D1F3E892-4604-464E-800E-922FD6C84A18</gtr:id><gtr:name>Medviso AB</gtr:name><gtr:address><gtr:line1>Griffelv?gen 3</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D269FD2E-8EBB-4D54-9C4E-3B7603EC2407"><gtr:id>D269FD2E-8EBB-4D54-9C4E-3B7603EC2407</gtr:id><gtr:name>Golden Jubilee National Hospital</gtr:name><gtr:address><gtr:line1>Golden Jubilee National Hospital</gtr:line1><gtr:line2>Beardmore Street</gtr:line2><gtr:line3>Clydebank</gtr:line3><gtr:postCode>G81 4HX</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/309D49C7-80B5-49D3-AD74-E3951564C59D"><gtr:id>309D49C7-80B5-49D3-AD74-E3951564C59D</gtr:id><gtr:name>Graz University of Technology</gtr:name><gtr:address><gtr:line1>Stremayrgasse 16/IV</gtr:line1><gtr:line4>Graz</gtr:line4><gtr:line5>A-8010</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Austria</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/983804C1-35E5-4939-9A22-D4BCF7ECFC6C"><gtr:id>983804C1-35E5-4939-9A22-D4BCF7ECFC6C</gtr:id><gtr:name>Dassault Systemes Simulia Corp</gtr:name><gtr:address><gtr:line1>Rising Sun Mills</gtr:line1><gtr:line2>166 Valley Street</gtr:line2><gtr:postCode>02909</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B6A26DF3-2014-41B5-A75E-26E713E865DD"><gtr:id>B6A26DF3-2014-41B5-A75E-26E713E865DD</gtr:id><gtr:name>Ansys Europe</gtr:name><gtr:address><gtr:line1>Southpointe</gtr:line1><gtr:line2>2600 ANSYS Drive</gtr:line2><gtr:postCode>15317</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8B397931-E408-4411-9815-5BECA5DCEFFA"><gtr:id>8B397931-E408-4411-9815-5BECA5DCEFFA</gtr:id><gtr:name>LGC Limited</gtr:name><gtr:address><gtr:line1>Queens Road</gtr:line1><gtr:postCode>TW11 0LY</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C1E9C787-1A64-4626-9702-3BA402E2D8CB"><gtr:id>C1E9C787-1A64-4626-9702-3BA402E2D8CB</gtr:id><gtr:name>Siemens Public Limited Company</gtr:name><gtr:address><gtr:line1>Sir Williams Siemens House</gtr:line1><gtr:line2>Princess Road</gtr:line2><gtr:postCode>M20 2UR</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/44E0FA2E-8099-4F24-9216-C863DADE282E"><gtr:id>44E0FA2E-8099-4F24-9216-C863DADE282E</gtr:id><gtr:name>Clyde Biosciences Ltd</gtr:name><gtr:address><gtr:line1>11 THE SQUARE UNIVERSITY OF GLASGOW 
UNIVERSITY AVENUE</gtr:line1><gtr:city>GLASGOW</gtr:city><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AC46C63D-F276-4BA8-96D0-CEF3B0E970D7"><gtr:id>AC46C63D-F276-4BA8-96D0-CEF3B0E970D7</gtr:id><gtr:name>NHS Greater Glasgow and Clyde</gtr:name><gtr:address><gtr:line1>Dalian House</gtr:line1><gtr:line2>PO Box 15329</gtr:line2><gtr:line3>350 St. Vincent Street</gtr:line3><gtr:postCode>G3 8YZ</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/281DBB2A-A236-42ED-9E7D-0260C5E0656F"><gtr:id>281DBB2A-A236-42ED-9E7D-0260C5E0656F</gtr:id><gtr:name>Institute for in silico Medicine</gtr:name><gtr:address><gtr:line1>The Pam Liversidge Building</gtr:line1><gtr:line2>Sir Frederick Mappin Building</gtr:line2><gtr:postCode>S1 3JD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FA76A058-C02A-4392-87C9-9E544C5C0038"><gtr:id>FA76A058-C02A-4392-87C9-9E544C5C0038</gtr:id><gtr:name>M D Anderson Cancer Center</gtr:name><gtr:address><gtr:line1>Box 447</gtr:line1><gtr:line2>1515 Holcombe Boulevard</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CA10F5D0-8E26-4790-BF21-025009DDA322"><gtr:id>CA10F5D0-8E26-4790-BF21-025009DDA322</gtr:id><gtr:name>Medical University of Graz</gtr:name><gtr:address><gtr:line1>Harrachgasse 21</gtr:line1><gtr:line4>Graz</gtr:line4><gtr:line5>A-8010</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Austria</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0347BD1B-2D97-4DF8-AF02-9772FA35606F"><gtr:id>0347BD1B-2D97-4DF8-AF02-9772FA35606F</gtr:id><gtr:name>Mosaiques Diagnostics AG</gtr:name><gtr:address><gtr:line1>Feodor-Lynen Strasse 21</gtr:line1><gtr:line4>Hannover</gtr:line4><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/501E8C35-C83C-41F2-8900-8EA80D8C53CE"><gtr:id>501E8C35-C83C-41F2-8900-8EA80D8C53CE</gtr:id><gtr:name>Fios Genomics Ltd</gtr:name><gtr:address><gtr:line1>ETTC</gtr:line1><gtr:line2>King's Buildings</gtr:line2><gtr:postCode>EH9 3JL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9AB78999-CAB7-401A-B3A4-0068465A9D2F"><gtr:id>9AB78999-CAB7-401A-B3A4-0068465A9D2F</gtr:id><gtr:name>Indian Institute of Science Bangalore</gtr:name><gtr:address><gtr:line1>2nd Floor, CAOS Building</gtr:line1><gtr:postCode>560 012</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>India</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9F03121C-0FF5-4D75-B76B-ADC337768524"><gtr:id>9F03121C-0FF5-4D75-B76B-ADC337768524</gtr:id><gtr:name>Ninewells Hospital &amp; Medical School</gtr:name><gtr:address><gtr:line1>PO BOX 120</gtr:line1><gtr:line4>Dundee</gtr:line4><gtr:line5>Angus</gtr:line5><gtr:postCode>DD1 9SY</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D3209431-1C22-482D-99B2-8B50ABA856E3"><gtr:id>D3209431-1C22-482D-99B2-8B50ABA856E3</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Chaplain</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4C759787-8657-48A8-A27C-742216C5456F"><gtr:id>4C759787-8657-48A8-A27C-742216C5456F</gtr:id><gtr:firstName>Raymond</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Ogden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B54BBE3E-FF39-4C4E-945D-4D780C603B6E"><gtr:id>B54BBE3E-FF39-4C4E-945D-4D780C603B6E</gtr:id><gtr:firstName>Dirk</gtr:firstName><gtr:surname>Husmeier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/25E8B145-0BE4-4B86-8620-7DD3760F3BED"><gtr:id>25E8B145-0BE4-4B86-8620-7DD3760F3BED</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Francis</gtr:otherNames><gtr:surname>Olson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B1CD89C4-8C42-4F1E-9119-9C1419471D90"><gtr:id>B1CD89C4-8C42-4F1E-9119-9C1419471D90</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Berry</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C78227C7-067F-4E86-838C-D27E3F2E2AE4"><gtr:id>C78227C7-067F-4E86-838C-D27E3F2E2AE4</gtr:id><gtr:firstName>Hao</gtr:firstName><gtr:surname>Gao</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6211F586-18D5-42F1-B7A8-233D019F4516"><gtr:id>6211F586-18D5-42F1-B7A8-233D019F4516</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Watton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7E668750-CE37-4A41-8B23-89D365175651"><gtr:id>7E668750-CE37-4A41-8B23-89D365175651</gtr:id><gtr:firstName>S</gtr:firstName><gtr:surname>McDougall</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/32713068-3DDF-446D-8C5B-B8D52BE38B3D"><gtr:id>32713068-3DDF-446D-8C5B-B8D52BE38B3D</gtr:id><gtr:firstName>Xiao Yu</gtr:firstName><gtr:surname>Luo</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E74BADDD-131F-4D3D-9D52-544F22CC7588"><gtr:id>E74BADDD-131F-4D3D-9D52-544F22CC7588</gtr:id><gtr:firstName>Radostin</gtr:firstName><gtr:otherNames>Dimov</gtr:otherNames><gtr:surname>Simitev</gtr:surname><gtr:orcidId>0000-0002-2207-5789</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/040BA87F-DD86-4447-BFC7-444060CF9B99"><gtr:id>040BA87F-DD86-4447-BFC7-444060CF9B99</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Insall</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BD5790CC-A375-4A48-978B-B8C7DCD54E01"><gtr:id>BD5790CC-A375-4A48-978B-B8C7DCD54E01</gtr:id><gtr:firstName>Huabing</gtr:firstName><gtr:surname>Yin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/998BE0B7-4CD4-4693-8E28-02EB80E3305A"><gtr:id>998BE0B7-4CD4-4693-8E28-02EB80E3305A</gtr:id><gtr:firstName>Nicholas Alaster</gtr:firstName><gtr:surname>Hill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1B9244B7-1006-430B-AB50-F3D7679377B7"><gtr:id>1B9244B7-1006-430B-AB50-F3D7679377B7</gtr:id><gtr:firstName>Godfrey</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/07159889-21DB-4A86-9945-3BA608CF2053"><gtr:id>07159889-21DB-4A86-9945-3BA608CF2053</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>S.</gtr:otherNames><gtr:surname>Stewart</gtr:surname><gtr:orcidId>0000-0002-0971-8057</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FN014642%2F1"><gtr:id>3249B16F-D867-4212-BA5E-2813818B2771</gtr:id><gtr:title>EPSRC Centre for Multiscale Soft Tissue Mechanics - with application to heart &amp;amp; cancer</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/N014642/1</gtr:grantReference><gtr:abstractText>In the diagnosis and treatment of disease, clinicians base their decisions on understanding of the many factors that contribute to medical conditions, together with the particular circumstances of each patient. This is a &amp;quot;modelling&amp;quot; process, in which the patient's data are matched with an existing conceptual framework to guide selection of a treatment strategy based on experience. Now, after a long gestation, the world of in silico medicine is bringing sophisticated mathematics and computer simulation to this fundamental aspect of healthcare, adding to - and perhaps ultimately replacing - less structured approaches to disease representation. 

The in silico specialisation is now maturing into a separate engineering discipline, and is establishing sophisticated mathematical frameworks, both to describe the structures and interactions of the human body itself, and to solve the complex equations that represent the evolution of any particular biological process. So far the discipline has established excellent applications, but it has been slower to succeed in the more complex area of soft tissue behaviour, particularly across wide ranges of length scales (subcellular to organ).

This EPSRC SoftMech initiative proposes to accelerate the development of multiscale soft-tissue modelling by constructing a generic mathematical multiscale framework. This will be a truly innovative step, as it will provide a common language with which all relevant materials, interactions and evolutions can be portrayed, and it will be designed from a standardised viewpoint to integrate with the totality of the work of the in silico community as a whole. In particular, it will integrate with the EPSRC MultiSim multiscale musculoskeletal simulation framework being developed by SoftMech partner Insigneo, and it will be validated in the two highest-mortality clinical areas of cardiac disease and cancer.

The mathematics we will develop will have a vocabulary that is both rich and extensible, meaning that we will equip it for the majority of the known representations required but design it with an open architecture allowing others to contribute additional formulations as the need arises. It will already include novel constructions developed during the SoftMech project itself, and we will provide many detailed examples of usage drawn from our twin validation domains. The project will be seriously collaborative as we establish a strong network of interested parties across the UK. The key elements of the planned scientific advances relate to the feedback loop of the structural adaptations that cells make in response to mechanical and chemical stimuli. A major challenge is the current lack of models that operate across multiple length scales, and it is here that we will focus our developmental activities. Over recent years we have developed mathematical descriptions of the relevant mechanical properties of soft tissues (arteries, myocardium, cancer cells), and we have access to new experimental and statistical techniques (such as atomic force microscopy, MRI, DT-MRI and model selection), meaning that the resulting tools will bring much-need facilities and will be applicable across problems, including wound healing and cancer cell proliferation. 

The many detailed outputs of the work include, most importantly, the new mathematical framework, which will immediately enable all researchers to participate in fresh modelling activities. Beyond this our new methods of representation will simplify and extend the range of targets that can be modelled and, significantly, we will be devoting major effort to developing complex usage examples across cancer and cardiac domains. The tools will be ready for incorporation in commercial products, and our industrial partners plan extensions to their current systems. 

The practical results of improved modelling will be a better understanding of how our bodies work, leading to new therapies for cancer and cardiac disease.</gtr:abstractText><gtr:potentialImpactText>Computers are increasingly being used to help doctors diagnose and treat disease, and new software is being developed to allow individual, patient-specific therapies. For this approach to be successful, two key issues need to be addressed. These are fundamental mathematical modelling to understand the biomechanical changes that occur in soft tissue in disease, and the development of techniques to deal with uncertainty in clinical measurements. SofTMech will carry out programmes of research by world-leading UK experts to give answers to these problems and, by developing detailed models of remodelling in the heart following a myocardial infarction (MI) and metastasis of breast carcinoma, provide computational examples that will enable healthcare technologists to translate the research into software to be used in clinical practice.

Heart disease is the leading killer in the world, responsible for about 30% of all deaths each year. Cancer is the second deadliest disease, and the World Health Organization projects that without immediate action, the global number of deaths from cancer will increase by nearly 80% by 2030. Together, these pose severe economic and medical challenges for the UK health care system. Consequently, SofTMech's research will have a major socioeconomic healthcare impact on the quality of life and health in the UK, and beyond, and enhance the UK's global competitiveness by addressing the most important healthcare problems. It is therefore of direct benefit to everyone in terms of improved quality of life and more efficient and cost-effective patient-specific treatment. 

Our research will generate a range of new mathematical models for studying these diseases. Developing predictive quantitative models of healing processes after a heart attack and of the biomechanics of cancer invasion will facilitate translational medical research to enhance diagnosis, treatment, and prevention. By developing test- and data-based modelling, we will examine how cellular changes affect stress and strain distributions within organs, what drives functional responses within cells, and which parameters are strongly associated with adverse remodelling leading to heart failure or cancer metastasis. This fundamental research will significantly advance our understanding of disease pathogenesis, diagnosis and responses to therapy, and hence move clinical research forward. This will be of direct benefit to patients and healthcare providers. For example, we will focus on developing in-depth myocardium mechanics models, linked to important subcellular organelle remodelling, that will increase our understanding of the mechanical status of a heart with a MI and help us suggest treatments to prevent progression of this disease to terminal heart failure. As a further example, we will explain how cancer cells become softer and thus better able to spread through surrounding tissue, to provide new targets for interventional therapies.

International engineering-software companies that provide computer code to describe the behaviour of advanced materials, such as our partners Simulia (Abaqus) and Ansys, and their customers in advanced technologies worldwide will benefit from advanced mathematical models that predict the behaviour of soft materials that SofTMech will develop, by incorporating these models into their widely used commercial software packages. Major medical imaging companies including Siemens, another of our partners, will benefit from using our models to better interpret signals from e.g. magnetic resonance and ultrasound scanning devices, which will further benefit patients and their doctors.

The Centre will raise awareness of our research to new and existing groups by networking activities, increase knowledge transfer by involving new clinical/industrial partners through training events, and influence the effectiveness of public services and policy by engagement with the Turing Gateway.</gtr:potentialImpactText><gtr:fund><gtr:end>2020-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2016-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1998908</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs><gtr:artisticAndCreativeProductOutput><gtr:description>Image created from the proceedings of the SofTMech Launch Event 2016-04-21.</gtr:description><gtr:id>8DC9EAFB-2441-4F8E-8C1D-02272A53796C</gtr:id><gtr:impact>Used on the SofTMech website for outreach purposes.</gtr:impact><gtr:title>SofTMech Cartoon 03</gtr:title><gtr:type>Image</gtr:type><gtr:url>http://www.softmech.org/media/media_464691_en.png</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Our events are recorded and published in youtube:
https://youtu.be/Ydo4G5VmSOo
https://youtu.be/mH8CgNYvRw8 

We also have updated animations of our modelling posted on YouTube since 2015 

https://www.youtube.com/watch?v=JcUNUmbCJSI
https://www.youtube.com/watch?v=Qko55MsoX8k
https://www.youtube.com/watch?v=dAX8xnykZJM</gtr:description><gtr:id>823A985B-59ED-4434-BC5F-214C8BCC1491</gtr:id><gtr:impact>This is hard to assess.</gtr:impact><gtr:title>YouTube</gtr:title><gtr:type>Film/Video/Animation</gtr:type><gtr:url>https://www.youtube.com/watch?v=JcUNUmbCJSI</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Image created from the proceedings of the SofTMech Launch Event 2016-04-21.</gtr:description><gtr:id>441DA974-C988-4C6A-8387-3D3A3762CF38</gtr:id><gtr:impact>Used on the SofTMech website for outreach purposes.</gtr:impact><gtr:title>SofTMech Cartoon 02</gtr:title><gtr:type>Image</gtr:type><gtr:url>http://www.softmech.org/media/media_464689_en.png</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Image created from the proceedings of the SofTMech Launch Event 2016-04-21</gtr:description><gtr:id>B23DF171-BC61-4BEA-AA41-858B5BC442DA</gtr:id><gtr:impact>Used on the SofTMech website for outreach purposes.</gtr:impact><gtr:title>SofTMech Cartoon 01</gtr:title><gtr:type>Image</gtr:type><gtr:url>http://www.softmech.org/media/media_464690_en.png</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput><gtr:artisticAndCreativeProductOutput><gtr:description>Images created from the proceedings of the SofTMech Dialogue on Heart Failure 2016-04-22.</gtr:description><gtr:id>252C26F4-5DE8-47D0-A611-F7834004E2E2</gtr:id><gtr:impact>Used on the SofTMech website for outreach purposes.</gtr:impact><gtr:title>SofTMech Cartoons  04 to 10</gtr:title><gtr:type>Image</gtr:type><gtr:url>http://www.softmech.org/events/2016-04-22dialogueonheartfailure</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:artisticAndCreativeProductOutput></gtr:artisticAndCreativeProductOutputs><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cardiovascular Research Day - Public Engagement, 14 March 2017</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>59E19A4E-B76A-483A-81A1-91D14EF20416</gtr:id><gtr:impact>Public engagement day in our hospital</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Researchers Night</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E1CE67DB-BC87-475A-8907-E3625CCDDD9D</gtr:id><gtr:impact>On September 30th SofTMech participated in the European Researcher Night outreach event at the Glasgow Science Centre. With attendance from over ten thousand visitors it was an excellent opportunity to present SofTMech to the public.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.softmech.org/news/headline_497928_en.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dialogue on Heart Failures</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>318FE42C-BC14-4EAB-BF54-9C550D649A12</gtr:id><gtr:impact>22nd April 16 brought together clinicians and modellers and created a focus to identify some of the crucial challenges in heart failure and disease over the next 20 years.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.softmech.org/events/2016-04-22dialogueonheartfailure/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SofTMech website</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8DD56920-CF43-4087-BF14-C1AF3613FB12</gtr:id><gtr:impact>Set up a SofTMech website. The website is a main vehicle for dissemination of results, news, events information, and general outreach activities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.softmech.org</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PubPhD talk &quot;Can cells be evil?&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>33F06165-7475-4EFD-B418-3D184F3FD64D</gtr:id><gtr:impact>&amp;quot;Pub PhD&amp;quot; talk &amp;quot;Can cells be evil?&amp;quot;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A Dialogue on Cancer</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4151538A-BC43-4D8E-9ECF-367CAC12D107</gtr:id><gtr:impact>This workshop was the second in a series of focussed meetings, co-funded by the EPSRC Network 'Predictive mOdelling for hEalthcare through MathS (POEMS)' and Centre for Multiscale Soft Tissue Mechanics (SoftMech). The focus of the workshop will be to bring together multidisciplinary groups (e.g. clinicians, biologists and modellers) and initiate dialogues and collaborations across disciplines, on challenges in relation to the mechanical and physical aspects of cancer.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://softmech.org/news/headline_499405_en.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>46379</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IAA project &amp;quot;Tracking biomarkers of heart attacks using a fast statistical emulator based on heart modelling and in vivo MRI&amp;quot;</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>EPSRC and CRUK</gtr:fundingOrg><gtr:id>08FFAF66-C6F3-442B-8058-EC36C90AA59C</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>281303</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Mathematics for Healthcare</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/N014642/1</gtr:fundingRef><gtr:id>E6A8D5B0-4466-48C4-AF5D-F618151C553D</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124991</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC First Grant Scheme</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/P024270/1</gtr:fundingRef><gtr:id>83F89289-A5A3-4FC0-B7A6-2C957C45731E</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>468095</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industrial funding</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>3F0E2C10-196C-4132-8EF0-0EB45E532EEE</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2017-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40943</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industrial funding</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>755220E1-93F3-4719-95DD-0DF246FAF80F</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The aim of the centre is to enhance the quality of life and health in the UK, and beyond, and enhance the UK's global competiveness by addressing the most important healthcare problems Heart disease, the leading killer in the world, and cancer the second deadliest disease. Our research will generate a range of new mathematical models for studying these diseases. This fundamental research will significantly advance our understanding of disease pathogenesis, diagnosis and responses to therapy, and hence move clinical research forward. 

The Centre started on 1st April 2016 and research is at an early stage of investigation. The delivery of planned Health/Wellbeing and Socio-Economic impacts, are dependent on the progress of our research, and are not anticipated till later stages of the research programme. 

To date our activities to facilitate impact delivery, which are detailed under engagement, have focused on
? Influencing professional practice by raising awareness of our activities to Professional practioners and seeking their views on some of the challenges associated with the research programme
? Influencing public behaviour by raising awareness of soft tissue mechanics to School children and the general public. 

SofTMech was awarded an Impact Acceleration Award, IAA project &amp;quot;Tracking biomarkers of heart attacks using a fast statistical emulator based on heart modelling and in vivo MRI&amp;quot;, which is detailed under Further Funding. The planned Socio-economic impacts include the aim of producing a useful computational toolkit for clinical research. The centre acted as focal point which attracted industrial support and greatly strengthened this application.

SofTMech has established a new collaboration with the pharmaceutical company GlaxoSmithKline on cardiac modelling. This has led to the GSK funding of &amp;gt;&amp;pound;1/2 million to support a three-year PDRA and a co-funded industrial PhD studentship to be based in SofTMech. Profs. Berry and Luo were also invited to give talks for the &amp;quot;International seminar&amp;quot; series at the GlaxoSmithKline's Headquarter in Stevenage on 20th Feb, 2017. The planned impacts from this are Healthcare and Socio-Economic.</gtr:description><gtr:firstYearOfImpact>2016</gtr:firstYearOfImpact><gtr:id>C9AC9CEF-3DD8-4F4F-8A7A-A802594F9859</gtr:id><gtr:impactTypes/><gtr:sector>Education,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Work Package WP1 - Mechanical Model of the Whole Cell

Our initial mechanical model is based on the continuum theory of nonlinear elasticity and uses both spherical and cylindrical models of a whole cell. The cell is considered as a simple isotropic elastic material surrounded by shell of anisotropic material aimed at modelling the subsurface F-actin network. A homogenized model for obtaining the overall elastic properties of such a two-layer composite cell has also been constructed, and this will be extended to incorporate other cell constituents such as the nucleus and stress fibres. Several numerical experiments using FEAP have been conducted related to contact and indentation of the model cell, and these can be used to compare with AFM results which will further inform the modelling. 

Indeed, development of a mechanical model of a whole cell requires experimental information of how intracellular components affect the overall elastic response. To achieve this, a novel single-cell bioanalysis platform has been developed that uses micropatterned surfaces of varying chemistries to influence cell cytoskeleton and function. Micropatterns of a range of shapes have been made, which have successfully controlled cell shape for both breast cancer cells (MDAMB231) and normal 3T3 fibroblasts. Furthermore, the micropatterns were designed to tune specific intracellular components locally (e.g., F-actin fibres) at a given overall shape, therefore allowing in-depth study of the role of each component. Methodologies for high-resolution fluorescence imaging and mechanical measurements of cells (viscous and elastic modules) have been established. Collection of experimental data is ongoing, and will provide a rich data profile to inform the development of the mechanical model. 

Work Package WP2 - Mechanobiological Models of Cell-Cell and Cell-ECM interactions

We have developed and extended our original individual-based, force-based model of cell-cell and cell-matrix interactions. We have carried out quite extensive simulations which vary key parameters in the model (cell-cell adhesion, cell-matrix adhesion) and in this way explored the effect of changes in the key parameters (representing mutations in the cancer cells) compared with a baseline set and known final output (e.g. the final number, size and shape of the solid tumour). We have incorporated a basic model of extracellular matrix fibres in 3D and are focussing on refining this in the coming months. Work has also progressed on coupling the lattice-free angiogenesis model from WP6 with our force-based, individual-based model. The formerly two separate codes have been combined, allowing for a unified model which is the first step towards a full model of a vascularized solid tumour (and also vascularized tissue which can be applied to model myocardial infarction). This will shortly enable us to investigate various aspects of cancer invasion, blood vessel infiltration (intravasation) and metastatic spread.

Work Package WP3 - Upscaling from Cells to Tissue

An initial numerical model has been developed and solved for a 1D line of connected rectangular hyperelastic cells subject to an initial displacement or compression using a simple linear drag force that is proportional to the cell's speed. Simple models of local cell growth have implemented. As an example, homogenization theory has been used to derive a novel partial differential equation for the tissue scale when cells are neo-Hookean. This work provides a foundation for extensions to 2D and 3D tissue structures and the use of more sophisticated cell-scale strain energy functions being developed in WP1.

We have conducted a comprehensive review of continuum mechanics models for soft tissues (primarily, myocardium), which has confirmed the need for a novel structure-based constitutive model for myocardium that incorporates more detailed microscale data than presently used. Several weak points in available models and modelling approaches, as well as potential ways to address them, have been identified. One example is the concept of material degradation within the growth and remodelling framework, which should be accurately refined, as existing interpretations may lead to an unphysical apparent strengthening due to the relation between mass densities and volume fractions of solid constituents. We have found, in particular, that existing models for myocardium do not capture the dispersion of the material directions or fibres in a way that is consistent and computationally efficient at the same time. We are now working towards a critical comparison of existing growth and remodelling approaches within a unifying framework that spans fibre reorientation, turnover, and the development of residual stress in order to improve understanding of their interactions.

Work Package WP4 - Parameter Inference and Model Selection

Statistical emulation for estimating 2 constitutive parameters of the left ventricle from 24 circumferential strains and the volume gives accurate results, with an error of less than 5%, and the emulated objective function is similar to the original one. When extending the inference problem to the simultaneous estimation of 9 constitutive parameters, the results critically depend on the space-filling design, and a projection into a 4-dimensional subspace defined by the constraints suggested from animal experiments appears to lead to an improvement in performance. 

A Gaussian process classifier applied to a subset of 6 constitutive parameters inferred from CMRI scans of 11 STEMI patients and 27 healthy volunteers achieves a sensitivity of 75% and a specificity of 95%.

Work Package WP5 - Multiscale Heart Modelling and Myocardial Infarction

In modelling the myocardium infarction (MI), we first focused on an 'extreme case study design'. Using our immersed boundary/finite element (IB/FE) left ventricular model with the structure-based Holzapfel-Ogden constitutive law, we studied 27 healthy volunteers and 11 patients with severe MI. The passive material parameters and myocardial contractility are inversely determined by matching the patient-specific LV motions at end-diastole and end-systole. Novel statistics parameter inference is used to assess the parameters. We compared 6 patients with severe LV systolic dysfunction following acute MI, 6 hyper-control subjects with no prior history of cardiovascular disease, normal systolic blood pressure, and 6 other age- and sex-matched control subjects with an increased systolic blood pressure. We found that normalised active contraction and fibre stress were highly discriminative between patients and controls at baseline. In particular, the myocytes dynamics and the required contractility have the strongest predicative power for cardiac function. In other words, these correlate strongly with the ejection fraction of the diseased heart at six-month post-MI.
Work Package WP6 Multiscale Solid Tumour Modelling

By developing a new capillary flow code in a platform-independent development environment, we have been able to directly simulate drug perfusion in murine glioblastomas and predict therapeutic delivery under a wide range of physiological conditions. This novel approach has led to new collaborative research with cell biologists and clinicians at Massachusetts General Hospital (Boston) and our first joint paper appeared in Royal Society Interface in December 2016. 

Work has also progressed on coupling the mechanobiological cell model from WP2 and the lattice-free angiogenesis model from WP6, allowing us to investigate various aspects of tumour infiltration and metastatic spread.

Work Package WP7 - Outreach and User Engagement

Key challenges which SofTMech identified, at pre-proposal stage, are the need to engage a range of stakeholders, (including industry, clinicians, healthcare professionals, patients and the public), to accelerate translation of the research; growth of research income and the development of real world impact). Since the formation of the centre, the user engagement and outreach committees have agreed a series of meetings to enable the delivery of engagement and outreach actions; put in place a number of communication tools, (website and newsletter), and organised a series of events (i.e. the Launch Event and Dialogues with Clinicians) to build user engagement.
A key finding from the work, to date, is that SofTMech has significant commercial interest in research areas outwith the original scope of SofTMech. To date this commercial interest has led to more than &amp;pound;500K of new funding from GSK.
As an indicator of engagement,147 people have subscribed to the SofTMech mailing list so far.</gtr:description><gtr:exploitationPathways>We shall publish all our findings in top international journals, make them open access, and present them at major international conferences and in our own soft tissue workshops, which will be held annually.

We shall enhance the uptake of our findings through our Dialogue events with clinicians and industries, and through industrial PhD studentships co-funded with industries, and through PDRA research funded by GlaxoSmithKline (GSK).

We shall organize and participate in public engagement events to make people aware of our findings. All of our activities will be highlighted in our e-news, uploaded to our website, and circulated to our members.</gtr:exploitationPathways><gtr:id>3B76FEFE-E679-4758-9CD6-95E4823B4777</gtr:id><gtr:sectors><gtr:sector>Education,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>This open source software can be used by any research groups who are interested in modelling fluid-structure interaction and soft tissues</gtr:description><gtr:id>C7C162AC-ACE8-469D-88F9-774F73008DB5</gtr:id><gtr:impact>We contributed to the develpment of this open source.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Open Source software, https://github.com/IBAMR/IBAMR</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>https://github.com/IBAMR/IBAMR</gtr:url></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Built on immersed boundary method with finite element extension, fluid-structure interaction of personalized human heart modeling approach is developed, and implemented in IBAMR framework. The computational framework IBAMR is freely available to anyone through https://github.com/IBAMR/IBAMR. Heart models are shared within the centre, but not to the public.</gtr:description><gtr:id>A1BEE656-4177-456B-B225-0AA55516EE0E</gtr:id><gtr:impact>By employing this approach, we studied the heart function between healthy volunteers and patients with acute myocardial infarction.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Immersed boundary method with finite element extension, with application to heart mechanics</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:url>https://github.com/IBAMR/IBAMR</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed finite element immersed boundary methods and used these to develop new models for mitral valve, left ventricle and various coupled systems.</gtr:description><gtr:id>E7EC161F-F726-4B5D-885C-3CAB3FED0989</gtr:id><gtr:impact>Our publications are cited by a number of other research groups, and we are invited to give talks at conferences/workshops</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Computational models and methodology</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:url>http://www.glasgowheart.org/</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Since 2012, Dr. Hao Gao, together with Prof. Colin Berry and Prof. Xiaoyu Luo, have been designing a novel method for tracking myocardial deformation using cardiac magnetic resonance cine imaging. Pixel-wise strain for myocardial deformation was estimated by incorporating both local and global myocardial features from cine images based on an in-house intensity-based b-spline deformable registration method. The algorithms were published in 2014 (https://www.ncbi.nlm.nih.gov/pubmed/24922458). Later, Dr. Gao developed an user-friendly interface for using in clinic, which are currently evaluated by our clinical collaborators for the accuracy and reliability. Results on healthy volunteers are reported in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5150576/. Following studies on patients with myocardial infarction are under analysis. Currently the package is shared within the group.</gtr:description><gtr:id>2F02BF2D-A44D-45C5-9651-95C795B06C2C</gtr:id><gtr:impact>Deformation-tracking could potentially obviate the need for bespoke strain sequences, reducing scanning time and is more reproducible than feature-tracking.</gtr:impact><gtr:title>Glasgow Cine Strain estimation from cine images--deformation tracking</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4EF365A5-DA92-43A0-8388-FCE125727360"><gtr:id>4EF365A5-DA92-43A0-8388-FCE125727360</gtr:id><gtr:title>A Novel Method for Estimating Myocardial Strain: Assessment of Deformation Tracking Against Reference Magnetic Resonance Methods in Healthy Volunteers.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87787baecf2b0f417f028caf8bca2842"><gtr:id>87787baecf2b0f417f028caf8bca2842</gtr:id><gtr:otherNames>Mangion K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D1A12B01-0961-4A33-87A4-B0033360C8A9"><gtr:id>D1A12B01-0961-4A33-87A4-B0033360C8A9</gtr:id><gtr:title>A Cell-Permeable Biscyclooctyne As a Novel Probe for the Identification of Protein Sulfenic Acids.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25a65ca931f062b2cd6c69aebf153bd4"><gtr:id>25a65ca931f062b2cd6c69aebf153bd4</gtr:id><gtr:otherNames>McGarry DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF86AC3B-97A1-4356-9A08-D3AA9FCE06D7"><gtr:id>FF86AC3B-97A1-4356-9A08-D3AA9FCE06D7</gtr:id><gtr:title>Propagation of dissection in a residually-stressed artery model.</gtr:title><gtr:parentPublicationTitle>Biomechanics and modeling in mechanobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1617-7940</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C6A33C41-4809-4978-AFEB-0A9663E6544F"><gtr:id>C6A33C41-4809-4978-AFEB-0A9663E6544F</gtr:id><gtr:title>Multimodality imaging and mathematical modelling of drug delivery to glioblastomas.</gtr:title><gtr:parentPublicationTitle>Interface focus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d97771f72d4353d417145dd1f3e400c8"><gtr:id>d97771f72d4353d417145dd1f3e400c8</gtr:id><gtr:otherNames>Boujelben A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2042-8898</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A91CE5F3-EBC4-4388-BEC5-C9EA23530114"><gtr:id>A91CE5F3-EBC4-4388-BEC5-C9EA23530114</gtr:id><gtr:title>Study of cardiovascular function using a coupled left ventricle and systemic circulation model.</gtr:title><gtr:parentPublicationTitle>Journal of biomechanics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/80e6f60d7b09797e5dc36b74093de5b8"><gtr:id>80e6f60d7b09797e5dc36b74093de5b8</gtr:id><gtr:otherNames>Chen WW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9290</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA1480FA-2049-4590-BA48-B2C468DB1B96"><gtr:id>AA1480FA-2049-4590-BA48-B2C468DB1B96</gtr:id><gtr:title>Inference of the drivers of collective movement in two cell types: Dictyostelium and melanoma.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e81383a0a41fad1a85100a7de6e42990"><gtr:id>e81383a0a41fad1a85100a7de6e42990</gtr:id><gtr:otherNames>Ferguson EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36DC7B87-C7B7-4205-8AEA-BB77ACE2C1F4"><gtr:id>36DC7B87-C7B7-4205-8AEA-BB77ACE2C1F4</gtr:id><gtr:title>A Mathematical Model on the Feedback Between Wall Shear Stress and Intimal Hyperplasia</gtr:title><gtr:parentPublicationTitle>International Journal of Applied Mechanics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/de0a49285ac93d5bd5b6357dd89d2168"><gtr:id>de0a49285ac93d5bd5b6357dd89d2168</gtr:id><gtr:otherNames>Goodman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/59035EE5-FAD9-422B-8C3C-43050063F06A"><gtr:id>59035EE5-FAD9-422B-8C3C-43050063F06A</gtr:id><gtr:title>A novel chemo-mechano-biological model of arterial tissue growth and remodelling.</gtr:title><gtr:parentPublicationTitle>Journal of biomechanics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d81c5a11eb28adf538a4168d6f369e8c"><gtr:id>d81c5a11eb28adf538a4168d6f369e8c</gtr:id><gtr:otherNames>Apar?cio P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9290</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD4017FB-8553-4D0D-8E82-EB86A85F70CC"><gtr:id>CD4017FB-8553-4D0D-8E82-EB86A85F70CC</gtr:id><gtr:title>Advances in Magnetic Resonance Imaging of the Myocardial Area at Risk and Salvage.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87787baecf2b0f417f028caf8bca2842"><gtr:id>87787baecf2b0f417f028caf8bca2842</gtr:id><gtr:otherNames>Mangion K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EBD567E4-0CFD-4036-A6E3-4AABD43A992D"><gtr:id>EBD567E4-0CFD-4036-A6E3-4AABD43A992D</gtr:id><gtr:title>An Invariant-Based Damage Model for Human and Animal Skins.</gtr:title><gtr:parentPublicationTitle>Annals of biomedical engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0090-6964</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B2B83E0-BC80-4383-9CE0-FDFC91D49A31"><gtr:id>0B2B83E0-BC80-4383-9CE0-FDFC91D49A31</gtr:id><gtr:title>Statistical inference of the mechanisms driving collective cell movement</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society: Series C (Applied Statistics)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c211a52200a89dbabffc60d24ac13e51"><gtr:id>c211a52200a89dbabffc60d24ac13e51</gtr:id><gtr:otherNames>Ferguson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FEFEADCE-0C6D-4235-A1E5-683B0113B05D"><gtr:id>FEFEADCE-0C6D-4235-A1E5-683B0113B05D</gtr:id><gtr:title>Inference in a Partial Differential Equations Model of Pulmonary Arterial and Venous Blood Circulation using Statistical Emulation</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0fad1c83535562bd2371964c03ad7650"><gtr:id>0fad1c83535562bd2371964c03ad7650</gtr:id><gtr:otherNames>Noe U.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/N014642/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>DEA11FBC-BEED-4EDD-890B-97D728462D26</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mathematical sciences</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>02B9E893-AC2F-436D-BF88-28E1AC827F5D</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Continuum Mechanics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>93E27C3B-6D00-4F18-BBE3-96C05C8F92B2</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Non-linear Systems Mathematics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>62309876-5C71-411C-B1A7-1B2907AFB5A8</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Statistics &amp; Appl. Probability</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>